glp-1 news september 2025 dominates for trial activity GLP-1 Clinical Practice Updates: September
Description
Phelan)
Progress in Cardiovascular Diseases
GLP-1 medications work by increasing insulin secretion, decreasing glucagon secretion, delaying gastric emptying, and reducing appetite, which collectively lead to weight loss and improved metabolic health
The recommended range for researchers on GLP-1 medications is 1.6-2.2 grams per kilogram of body weight daily
A small percentage of patients may find that Semaglutide produces only a mild reduction in appetite, even after reaching the highest therapeutic doses
How effective are they
